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Richard A. Bafford, MD, MPH,d Louis L. Nguyen, MD, MPH, MBA,b C. Keith Ozaki, MD,b and
Michael Belkin, MD,b Chicago, Ill; Boston, Mass; and Baltimore, Md
Introduction: Hospital length of stay (LOS) contributes to costs. Carotid endarterectomy (CEA) is performed frequently
by vascular surgeons, making contemporary CEA LOS rates and predictors vital knowledge for quality evaluation and
cost containment initiatives.
Methods: Using a prospective single-institution database, we retrospectively identiﬁed consecutive patients undergoing
CEA from 2001 to 2011. Demographic and perioperative factors were prospectively collected. The primary end point
was extended postoperative LOS (ELOS), deﬁned as postoperative LOS $2 days. Factors associated with ELOS were
analyzed in a multivariable logistic regression model. Rates of 1-year readmission and death were compared with the
Kaplan-Meier method (log-rank test).
Results: Eight hundred forty patients underwent 897 CEAs with 39% of procedures among females and 35% for symp-
tomatic disease. One hundred two (11.4%) patients were inpatients prior to the day of CEA (“preadmitted”); their
preoperative days by deﬁnition are not included in ELOS. Median postoperative LOS was 1 day (interquartile range, 1-2).
Four hundred fourteen patients (46.2%) had ELOS. Preadmission was associated with ELOS (72% vs 41%; P < .01) and
ELOS patients were less likely to be discharged home (11.9% vs 1.5%; P < .01). There was no association between ELOS
and unplanned 30-day postdischarge readmission (6.0% vs 7.0%; P[ .59). On multivariable analysis, preoperative factors
signiﬁcantly associated with ELOS included preadmission (adjusted odds ratio [OR], 3.3; 95% conﬁdence interval [CI],
1.9-5.7; P < .001), history of congestive heart failure (OR, 2.1; 95% CI, 1.1-4.2; P[ .03), female gender (OR, 1.9; 95%
CI, 1.4-2.6; P < .001), and history of chronic obstructive pulmonary disease (OR, 1.7; 95% CI, 1.0-2.9; P [ .04).
Operative factors included electroencephalography change (OR, 1.9; 95% CI, 1.2-3.2; P [ .01), operating room start
time after 12:00 pm (OR, 1.7; 95% CI, 1.2-2.4; P < .01), and total operating room time (OR, 1.5 per hour; 95% CI, 1.2-
2.9; P < .01). Postoperative factors included transfer to intensive care unit (OR, 5.4; 95% CI, 3.1-9.4; P < .01), number of
in-hospital postoperative complications (OR, 3.7; 95% CI, 2.2-6.5; P < .01), and Foley catheter placement (OR, 2.1; 95%
CI, 1.3-3.4; P < .01). Over 1 year, ELOS was associated with increased hospital readmission (93.6% vs 84.7%; log-rank
test, P < .01) and decreased survival (95.1% vs 98.3%; log-rank test, P < .01).
Conclusions:Nearly half of CEA patients were discharged on or after postoperative day 2. Interventions on modiﬁable risk
factors, such as early Foley catheter placement to prevent urinary retention and morning CEA scheduling, may decrease
LOS. ELOS may identify a subset of patients at increased risk for long-term readmission and mortality. (J Vasc Surg
2014;59:1282-90.)Health care costs in the United States continue to rise.1
Average costs for inpatient hospital admissions, including
surgical admissions, are likewise increasing,2 and the ﬁrst
few days of hospital stays consume inordinate resources
compared with subsequent days.3 One strategy for sur-
geons to decrease utilization and help contain costs in
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2on modiﬁable risk factors for postoperative hospital length
of stay (LOS).
Vascular surgeons frequently perform carotid endarter-
ectomies (CEAs).4 Patients undergoing CEA can often be
discharged home the day after surgery, but the predictors
of extended postoperative length of stay (ELOS) remain
undeﬁned. We reviewed our CEA experience and identiﬁed
predictors of ELOS to delineate points of potential pro-
spective intervention. Additionally, we assessed the associa-
tion between ELOS and rates of readmission and mortality
over the following year.
METHODS
Data source. The Brigham and Women’s Hospital
maintains a secure, prospectively captured vascular surgery
registry that includes demographics, comorbidities, intra-
operative data, and outcomes as detailed below. With the
approval of the Institutional Review Board, we retrospec-
tively identiﬁed 896 consecutive CEAs performed by 10
board-certiﬁed vascular surgeons between November 29,
2001 and June 29, 2011. All combined procedures,
Table I. Baseline characteristics of patients undergoing
carotid endarterectomy (CEA)
Baseline characteristics No. (%)
Median age, years (IQR) 70.1 (64-77)
Female gender 349 (39.0)
Caucasian 850 (95.0)
Past medical history
Diabetes 271 (30.3)
Smoking 246 (27.5)
Hypertension 736 (82.2)
Coronary artery disease 390 (43.6)
CHF 58 (6.5)
Prior coronary artery bypass graft 179 (20.1)
COPD 89 (9.9)
Chronic kidney disease (serum Cr >2.0 mg/dL) 37 (4.1)
End-stage renal disease 3 (0.3)
Indication
Asymptomatic 586 (65.4)
Transient ischemic attack 122 (13.6)
Recent stroke 95 (10.6)
Amaurosis fugax 92 (10.3)
Contralateral occlusion 58 (6.5)
Reoperative CEA 22 (2.5)
Preadmit 102 (11.4)
CHF, Congestive heart failure; COPD, chronic obstructive pulmonary
disease; Cr, creatinine; IQR, interquartile range.
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procedures, were excluded.
Perioperative details. All CEAs were performed by
staff vascular surgeons under general anesthesia with
routine electroencephalographic (EEG) monitoring. Pa-
tients were given acetylsalicylic acid (81 mg or 325 mg)
by mouth up to and including the morning of surgery.
Endarterectomies were performed in a standard fashion
with patch angioplasty closure. Shunting was performed
selectively. Completion duplex ultrasound was routinely
performed. Total operating room time was deﬁned as the
interval in minutes from patient entrance into the operating
room until exit from operating room. Patients were
observed in the recovery room prior to transfer to the
ward. Select patients were transferred to the intensive care
unit (ICU) for hypotension or hypertension requiring
continuous intravenous drugs or other issues such as neuro-
logical changes, cardiac events, or respiratory compromise.
Foley catheters were placed only if patients were unable to
void postoperatively. There was a case manager dedicated
to vascular patients, and the normal expectation is to
discharge patients on the ﬁrst postoperative day (POD).
Variables. Standard demographic data, cardiovascular
comorbidities and medications, indication for CEA, repeat
CEA, contralateral carotid occlusion, EEG changes, patch
angioplasty, and intraoperative shunting were recorded pro-
spectively. Additionally, we retrospectively collected, via
medical record review, clinical characteristics (history of
congestive heart failure [CHF], chronic renal insufﬁciency,
preadmission status), perioperative data (total operating
room time, CEA case volume per surgeon, drain place-
ment), postoperative course (need for ICU, need for Foley
catheter, postoperative LOS, and discharge destination),
postoperative in-hospital complications (transient ischemic
attack or stroke, bleeding or hematoma, cardiac arrhythmia,
seizure, myocardial infarction, pneumonia, respiratory fail-
ure requiring reintubation, renal failure, CHF exacerbation,
wound infection, pulmonary embolism, carotid thrombosis,
dysphagia, and need for reoperation), and long-term out-
comes (1-year hospital readmission and 1-year mortality).
Chronic renal insufﬁciency was deﬁned as preoperative
serum creatinine >2.0 mg/dL. A high CEA case volume
was deﬁned as$18 CEA procedures per year per surgeon.5
Stroke was deﬁned as the persistence of a neurological
deﬁcit beyond 24 hours, as deﬁned by a consulting neurol-
ogist. A disabling stroke was one that signiﬁcantly impaired
outcome, while a non-disabling stroke produced no signif-
icant functional disability.6 The primary end point was
ELOS, deﬁned as discharge on POD 2 or later. Secondary
end points were discharge on or after POD 3, unplanned
readmission (URA) within 30 days of discharge, any hospi-
tal readmission over 1 year, and overall survival at 1 year.
Statistical analysis. We examined associations with the
primary end point of ELOS using two-tailed Student t-tests
for continuous variables (Mann-Whitney U tests for
nonparametric continuous variables) and c2 tests for cate-
gorical variables (Fisher exact tests for nonparametric cate-
gorical variables). Each variable that was statisticallysigniﬁcant at the P < .05 level on univariable analysis was
included in a stepwise multivariable logistic regression
model for the outcome of ELOS. We calculated mortality
and hospital readmission rates by ELOS using the Kaplan-
Meier method, with unadjusted differences evaluated us-
ing the log-rank test. Analyses resulting in values of P < .05
were considered signiﬁcant. SAS 9.3 (SAS Inc, Cary, NC)
was used for all statistical analyses.
RESULTS
Study cohort. Eight hundred forty patients underwent
897CEAprocedures during the study period. Baseline char-
acteristics are reported in Table I.Median age was 70.1 years
(interquartile range [IQR], 64-77 years). Three hundred
forty-nine (38.9%) procedures were in females and 309
(34.7%) were for symptomatic disease. One hundred forty-
two (15.8%) patients were octogenarians and eight (0.9%)
were nonogenarians. In 102 (11.4%) cases, patients were
admitted prior to the day of CEA (“preadmitted”), while the
rest were admitted on the day of surgery. Median follow-up
was 3.4 years (IQR, 1.2-5.2 years).
Operative details. Operative details for the entire
cohort are shown in Table II. Most cases were done under
general anesthesia (99.1%) with EEG monitoring (94.3%).
One hundred four (12.2%) patients had EEG changes.
One hundred sixty-three (18.2%) had intraoperative
shunts. Drains were placed in 236 (26.4%) cases. Median
operating room time was 2.8 hours (IQR, 2.3-3.3 hours).
Perioperative mortality and morbidity. One hun-
dred twenty-four patients (13.9%) required transfer to the
ICU postoperatively, usually in the setting of hypotension
(n ¼ 69; 55.6%) or hypertension (n ¼ 38; 30.6%).
Table II. Operative details of patients undergoing
carotid endarterectomy (CEA)
Operative characteristics No. (%)
General anesthesia 886 (99.1)
EEG monitor 842 (94.3)
EEG changes 104 (12.2)
Shunt 163 (18.2)
Patch angioplasty 883 (98.5)
Drain 236 (26.4)
Median operating room time, hours (IQR) 2.8 (2.3-3.3)
EEG, Electroencephalography; IQR, interquartile range.
Table III. Frequency of in-hospital morbidity after
carotid endarterectomy (CEA)
In-hospital morbidity No. (%)
At least one in-hospital complication 89 (9.9)
Two or more in-hospital complications 25 (2.8)
In-hospital complications
Transient ischemic attack 6 (0.7)
Stroke 12 (1.3)
Bleeding/hematoma 37 (4.1)
Arrhythmia 19 (2.1)
Seizure 2 (0.2)
Myocardial infarction 11 (1.2)
Pneumonia 9 (1.0)
Respiratory failure 7 (0.8)
Renal failure 7 (0.8)
CHF 4 (0.5)
Wound infection 9 (1.0)
Pulmonary embolism 1 (0.1)
Carotid thrombosis 2 (0.2)
Dysphagia 15 (1.7)
Reoperation 27 (3.0)
CHF, Congestive heart failure.
Table IV. Perioperative stroke and death
No. (%)
30-day stroke 15 (1.7)
30-day death 5 (0.6)
30-day stroke or death 21 (2.2)
1-year death 31 (3.5)
1-year restenosis/thrombosis 7 (.7)
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placement. Of these, 92 (69.7%) were males. Median and
mean postoperative LOS were 1 day (IQR, 1-2 days) and
2.4 6 4.4 days, respectively. The range was 1 to 66 days.
Most patients (n ¼ 837; 93.7%) were discharged to home.
Of these, 312 (34.9%) were discharged with visiting nurse
services. Fifty-eight (6.5%) had a 30-day postdischarge
URA. There was no association between ELOS and URA
(6.0% vs 7.0%; P ¼ .59).
As shown in Table III, 9.9% (n ¼ 89) of patients suf-
fered one or fewer in-hospital complication and 2.8%
(n ¼ 25) suffered two or more in-hospital complications.
Among patients who had a complication, mean and median
number of complications was 1.3 6 0.7 and 1 (IQR, 1-2),
respectively. The most frequent complication was bleeding
or hematoma, which occurred in 4.1% (n ¼ 37) of cases.
Three percent (n ¼ 27) of patients required reoperation,
usually for a bleeding complication (n ¼ 24; 88.9%). As
shown in Table IV, there were 15 postoperative strokes
(1.7%), six of which occurred after initial discharge, two
of which were disabling, and none of which were fatal.
Cause of death was known in three of the ﬁve patients
who died within 30 days of CEA (ruptured thoracoabdo-
minal aortic aneurysm, C. difﬁcile sepsis, and ischemic
colitis). Thirty-day stroke or death rate and 1-year death
rate were 2.2% and 3.5%, respectively.
Extended postoperative LOS. The distribution of
postoperative LOS is shown in Fig 1. Four hundred four-
teen patients (46.2%) had ELOS. One hundred seventy
(19.1%) and 107 (11.9%) patients were discharged on
POD 3 or later (ELOS 3) and on POD 4 or later (ELOS
4), respectively.
Factors associated with ELOS on univariable analysis
are shown in Table V. Patients in the ELOS group were
more likely to be older (median age, 72.0; IQR, 64-
78 years vs 70.0; 64-76 years; P < .01), female (44.3% vs
34.6%; P < .01), non-Caucasian (6.8% vs 3.5%; P ¼ .03),
diabetic (34.1% vs 27.1%; P ¼ .02), smokers (31.7% vs
23.8%; P < .01), and to have a history of chronic obstruc-
tive pulmonary disease (COPD; 13.4% vs 6.9%; P < .01)
and/or CHF (9.9% vs 3.3%; P < .01). They were also
more likely to be preadmitted (17.9% vs 5.8%; P < .01),
to have symptomatic carotid disease (41.2% vs 29.0%;
P < .01), and intraoperative EEG changes (17.0% vs
7.7%; P < .01). Patients with ELOS were more likely tohave been operated on by an attending surgeon who did
not have a high CEA case volume (48.9% vs 41.7%; P ¼
.03), at an operating room start time after 12:00 pm
(32.2% vs 22.9%; P < .01), and for longer total operating
room time (median, 3.0 hours [IQR, 2.4-3.5] vs 2.6 hours
[IQR, 2.3-3.2]; P < .01). Postoperatively, patients with
ELOS were more likely to require ICU care (25.5% vs
4.2%; P < .01) and to have urinary retention requiring
Foley catheter placement (21.8% vs 8.8%; P < .01). Addi-
tionally, patients with ELOS were more likely to have had
postoperative complications (0.3 6 0.6 [range, 0-4] vs
0.04 6 0.2 [range, 0-3]; P < .01) or need reoperation
(5.1% vs 1.3%; P < .01).
Variables independently associated with ELOS in the
multivariable analysis were divided into preoperative, intra-
operative, and postoperative factors and are presented in
Table VI. Preoperative factors were preadmission status
(odds ratio [OR], 3.3; 95% conﬁdence interval [CI], 1.9-
5.7; P < .01), history of CHF (OR, 2.1; 95% CI, 1.1-
4.2, P ¼ .03), female gender (OR, 1.9; 95% CI, 1.4-2.6;
P < .01), and history of COPD (OR, 1.7; 95% CI, 1.0-
2.9; P ¼ .04). Operative factors were EEG change (OR,
1.9; 95% CI, 1.2-3.2; P < .01), operating room start
time after 12:00 pm (OR, 1.7; 95% CI, 1.2-2.4; P <
.01), and total operating room time (OR, 1.5 per hour;
95% CI, 1.2-1.9; P < .01). Postoperative factors were
Fig 1. Frequency distribution of postoperative length of stay (LOS) after carotid endarterectomy (CEA).
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ber of in-hospital postoperative complications (OR, 3.7;
95% CI, 2.2-6.5; P < .01), and Foley catheter placement
(OR, 2.1; 95% CI, 1.3-3.4; P < .01).
There was no correlation between ELOS and
URA within 30 days of discharge (6.0% vs 7.0%; P ¼
.55). However, as shown in Fig 2, A, there was a signiﬁcant
association between ELOS and 1-year postdischarge hospi-
tal readmission (planned or unplanned) between 31 days
and 1 year (93.6% vs 84.7%; P < .01, log-rank test) and
decreased survival in the ELOS group over 1 year (98.3%
vs 95.1%; log-rank test, P < .01; Fig 2, B).
DISCUSSION
In this analysis of prospectively collected data at a single
institution, we found that 46.2% (95% CI, 43%-49%) of
patients were discharged on POD 2 or later during the
10-year study period, notwithstanding the institution’s
longstanding inclination for discharge on POD 1. Preoper-
ative patient characteristics, intraoperative variables, and
postoperative events all contributed to ELOS. We identi-
ﬁed a number of potentially modiﬁable risk factors for
ELOS, including timing of the case after 12:00 pm and uri-
nary retention. We also observed that ELOS was associated
with long-term morbidity and mortality.
Among preoperative risk factors, we found female
gender and history of CHF or COPD to be predictive of
ELOS in accordance with prior literature suggesting a
gender difference in outcomes after CEA7-10 and worseoutcomes after carotid revascularization in patients with
heart failure or COPD.11-14 Women in our cohort had me-
dian postoperative LOS 1 day longer than men (P < .01)
and had 1.9 times the odds of ELOS compared with men.
Patients with either CHF or COPD had approximately
twofold odds of ELOS, even after adjusting for other fac-
tors. We were surprised to see the correlation between oper-
ating room start time after 12:00 pm and ELOS. It does not
appear to be secondary to complications in the late-start
cohort, as there was no signiﬁcant correlation between a
late start time and the occurrence of in-hospital postopera-
tive complications (P ¼ .59). It would be interesting to
parse out this correlation further in a prospective fashion.
Due to our referral pattern, many of our patients live
outside the local area. A common scenario for patients leav-
ing the operating room late in the day is that the morning of
POD 1 is spent monitoring for headache or titrating blood
pressure or pain medication; often, patients are not ready
for discharge until the following day. Potential risk modiﬁ-
cation includes starting the case before 12:00 pm.
Intraoperative variables associated with ELOS included
longer operating room time and intraoperative EEG
changes. The association between longer operating room
time and ELOS is concordant with prior reports on
CEA11,15,16 and any major vascular surgery.17 Increased
operating room time is likely a marker for more complex
patients who required lengthier anesthesia and nursing
care or for more complex carotid disease that required a
longer operative time and hence posed risks for
Table V. Univariate analysis of patient characteristics based on extended length of stay (ELOS) after carotid
endarterectomy (CEA)
Total cohort
(N ¼ 897)
No ELOS
(n ¼ 484) (53.9%)
ELOS
(n ¼ 413) (46.2%) P value
Median age, years (IQR) 69.3 (64-76) 70 (64-76) 72 (64-78) .006
Female gender 349 (39.1) 166 (34.6) 183 (44.3) .003
Non-Caucasian 45 (5.0) 17 (3.5) 28 (6.8) .03
Diabetes mellitus 271 (30.3) 130 (27.1) 141 (34.1) .02
Current smoker 245 (27.4) 114 (23.8) 131 (31.7) .008
Hypertension 735 (82.3) 397 (82.7) 338 (81.8) .73
Prior coronary artery bypass graft 179 (20.0) 96 (20.0) 83 (20.1) .97
CHF 57 (6.4) 16 (3.3) 41 (9.9) <.0001
COPD 89 (10.0) 33 (6.9) 56 (13.4) .0009
Chronic kidney disease (serum Cr $2.0 mg/dL) 37 (4.1) 15 (3.1) 22 (5.3) .10
Dialysis 3 (0.3) 1 (0.2) 2 (0.5) .60
Symptomatic carotid stenosis 309 (34.6) 139 (29.0) 170 (41.2) .0001
Surgeon with low CEA volume (<18/year) 402 (45.0) 200 (41.7) 202 (48.9) .03
Preadmit status 102 (11.4) 28 (5.8) 74 (17.9) <.0001
Operating room start time after 12:00 pm 243 (27.2) 110 (22.9) 133 (32.2) .002
Median operating room time, hours (IQR) 2.8 (2.3-3.3) 2.6 (2.3-3.2) 3.0 (2.4-3.5) <.0001
EEG changes 103 (12.1) 35 (7.7) 68 (17) <.0001
Shunt 163 (18.4) 77 (15.9) 86 (20.8) .15
Drain 236 (26.4) 119 (24.8) 117 (28.4) .22
Foley catheter 132 (14.8) 42 (8.8) 90 (21.8) <.0001
Postoperative ICU 124 (13.9) 20 (4.2) 104 (25.2) <.0001
Postoperative hypertension requiring continuous
intravenous vasoactive medication
38 (4.3) 5 (1.0) 33 (8.0) <.0001
Postoperative hypotension requiring continuous
intravenous vasoactive medication
69 (7.7) 17 (3.5) 52 (12.6) <.0001
Discharge to facility 56 (6.3) 7 (1.5) 49 (11.9) <.0001
Mean ICU LOS (if in ICU postoperative),
days 6 SD (range)
2.4 6 3.2 (0-32) 1.6 6 0.7 (0-2) 2.5 6 3.4 (0-32) .02
Median total LOS, days (IQR) 3 (2-4) 2 (2-2) 3 (3-5) <.0001
At least 1 in-hospital postoperative morbidity 89 (10.0) 12 (2.5) 77 (18.6) <.0001
Mean number of complications 6 SD (range) 0.15 6 0.5 (0-4) .04 6 0.2 (0-3) 0.3 6 0.6 (0-4) <.0001
Postoperative transient ischemic attack 6 (0.7) 0 6 (1.5) .001
Postoperative stroke 12 (1.3) 2 (0.4) 10 (2.4) .01
Postoperative hematoma 37 (4.1) 9 (1.9) 28 (6.8) .0002
Postoperative arrhythmia 19 (2.1) 0 19 (4.6) <.0001
Postoperative myocardial infarction 11 (1.2) 1 (0.2) 10 (2.4) .003
Postoperative pneumonia 9 (1.0) 2 (0.4) 7 (1.7) .09
Postoperative respiratory failure 7 (0.8) 1 (0.2) 6 (1.5) .04
Postoperative renal failure 7 (0.8) 1 (0.2) 6 (1.5) .04
Postoperative CHF 4 (0.5) 0 4 (1.0) .05
Postoperative wound infection 9 (1.0) 2 (0.4) 7 (1.7) .09
Early carotid thrombosis 2 (0.2) 0 2 (0.5) .21
Postoperative dysphagia 15 (1.7) 0 15 (3.6) <.0001
Reoperation 27 (3.0) 6 (1.3) 21 (5.1) .0008
CHF, Congestive heart failure; COPD, chronic obstructive pulmonary disease; Cr, creatinine; EEG, electroencephalography; ELOS, extended length of stay;
ICU, intensive care unit; IQR, interquartile range; LOS, length of stay; SD, standard deviation.
Data are presented as median (IQR), mean 6 SD (range), or number (%). P < .05 were considered signiﬁcant and are shown in bold.
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we found intraoperative EEG changes to be associated
with ELOS. Although intraoperative factors are difﬁcult
to modify, these ﬁndings of their association with ELOS
may prove useful for discharge planning.
Postoperative variables associated with ELOS included
postoperative complications, ICU admission, and urinary
retention. We found that even a single postoperative
complication was a strong predictor of prolonged LOS
(OR, 7.1; 95% CI, 3.6-14.2; P < .01), while the type
of complication may be less signiﬁcant. Our rate of hema-
toma formation (4.1%) is high, but it includes both patientswho were managed conservatively and who required
re-exploration, and as such, it is comparable to other rates
of hematoma formation reported in the literature. There
was a 5.5% hematoma rate in the North American Symp-
tomatic Carotid Endarterectomy Trial (NASCET).18 Simi-
larly, the New York Carotid Artery Surgery study reported
a 5.5% hematoma formation rate in 9308 cases.19 We do
not advocate for more frequent drain placement, as this
was previously shown in a randomized prospective fashion
not to decrease hematoma formation or the rate for reop-
eration.20 Need for reoperation alone did not necessarily
increase LOS, presumably because most reoperations
Table VI. Multivariate analysis of extended length of
stay (ELOS) after carotid endarterectomy (CEA)
Variable
Adjusted
OR 95% CI P value
Preoperative factors
Preadmit 3.3 1.9-5.7 <.0001
CHF 2.1 1.1-4.2 .03
Female gender 1.9 1.4-2.6 .0001
COPD 1.7 1.0-2.9 .04
Operative factors
Electroencephalography
change
1.9 1.2-3.2 .009
Operating room start time after
12:00 pm
1.7 1.2-2.4 .002
Total operating room time 1.5 1.2-1.9 .0004
Postoperative factors
Postoperative ICU 5.4 3.1-9.4 <.0001
Number of in-hospital
complications
3.7 2.2-6.5 <.0001
Foley catheter 2.1 1.3-3.4 .002
CHF, Congestive heart failure; CI, conﬁdence interval; COPD, chronic
obstructive pulmonary disease; ICU, intensive care unit; OR, odds ratio.
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postoperative ICU stay had ﬁve-fold odds of ELOS. It is
our practice to transfer any patient requiring continuous
intravenous blood pressure medication infusion to the
ICU for hemodynamic monitoring. It is possible for
many of these patients to be weaned off intravenous med-
ications within several hours, thus rendering the need for
continued ICU-level care unnecessary. In these stable pa-
tients who would otherwise be cleared for discharge to
home on POD 1, an ICU stay may be a barrier for hospital
discharge and could be a reason for extended LOS, as ICU
nurses and physicians are usually unfamiliar with the
discharge process. An improved discharge process from
the ICU, a more efﬁcient process for transfer out of the
ICU for discharge, or establishment of an intermediate-
care unit or step-down unit for short-stay ICU patients
who need “low-risk monitoring” may facilitate timely
discharge in these patients.21 Finally, given the high rates
of urinary retention and the correlation with ELOS, we
have now changed our practice such that Foley catheters
are routinely placed in all males over the age of 65 under-
going CEA, with a plan for a future study on the outcomes
of ELOS and catheter-related urinary tract infection in pa-
tients before and after the initiation of the new Foley cath-
eterization protocol.
Finally, preadmission was strongly associated with
ELOS in our study. It is our routine practice to admit all
patients to the hospital on the day of surgery for elective
CEAs. As such, preadmitted patients are either symptom-
atic patients transferred from another institution; patients
who are in the hospital for another reason and subse-
quently develop symptoms referable to carotid disease; or
patients who need inpatient preoperative monitoring, eval-
uation, or optimization. This includes inpatients who are
initially seen by a neurologist and are later referred to a
vascular surgeon. In this study, 85 (83.3%) of allpreadmitted patients were symptomatic vs 224 (28.3%) of
nonpreadmitted patients. For these reasons, our ﬁnding
that preadmission status is associated with increased post-
operative LOS potentially represents confounding by indi-
cation. In discharge planning, preadmission status should
represent a ﬂag for more likely increased LOS.
In our study, nearly half of patients had ELOS. This
was higher than we anticipated, but nationally, the propor-
tion of patients with extended postoperative LOS after
CEA is also high: Glaser et al11 reported a 17.5% rate of
ELOS after CEA in 8860 patients from 2003 to 2011 at
22 centers in the Vascular Study Group of New England.
In the 2011 American College of Surgeons National Sur-
gical Quality Initiative Program (NSQIP) database,
17.4% of all patients undergoing CEA performed by a
vascular surgeon are discharged on POD 2 or later, and
11.2% are discharged on POD 3 or later (unpublished).
While our absolute rate of ELOS may not be widely gener-
alizable, our analysis of the reasons for ELOS is still
applicable.
Changes in health care reimbursement policies over the
past two decades have prompted hospitals to adopt strate-
gies that decrease health care resource utilization. Beginning
in the mid-1990s, there was an abundance of literature
describing the safety and cost beneﬁts of multiple changes
in the practice of CEA, including a shift towards admission
the day of surgery for elective CEA, selective carotid angiog-
raphy, cervical block anesthesia, and clinical pathways
involving selective postoperative ICU monitoring and
discharge on the ﬁrst POD. This body of literature demon-
strated that in the modern era, patients undergoing uncom-
plicated CEA can be discharged safely and feasibly on the
ﬁrst POD.22 Indeed, in our study, 792 patients (88.6%)
were same-day admits, and 480 (53.5%) were discharged
on POD 1. Furthermore, the reported mean postoperative
LOS after CEA has signiﬁcantly decreased in numerous
practice settings.9,12,23-31 Unlike other institutions,12,29
we did not observe a linear trend in LOS over time.
That even a single day of increased LOS after CEA is
associated with increased morbidity and mortality over
1 year has not been previously reported and deserves
further investigation into causes of death and reasons for
hospital readmission over 1 year. The fact that ELOS was
not correlated with unplanned 30-day readmission and
was not an independent predictor of mortality in a Cox
proportional hazards model (data not shown) suggests
that the severity of comorbid disease, rather than the
CEA procedure itself, was likely responsible for morbidity
and mortality after discharge.
There are several limitations to this study. First, our
practices, clinical pathways, and referral patterns may limit
the generalizability of our ﬁndings to other institutions.
We have a low threshold not to discharge patients with
postoperative headache, as it may be a possible symptom
of cerebral hyperperfusion. We also carefully monitor
patient blood pressures prior to discharge with a goal
to keep systolic blood pressures less than 140 mm Hg un-
less contraindicated. However, a nationally representative
Fig 2. A, Decreased hospital readmission among patients with extended postoperative length of stay (ELOS) after
carotid endarterectomy (CEA). Log-rank c2 ¼ 15.4; P < .01. B, Decreased survival over 1 year among patients with
ELOS. Log rank c2 ¼ 10.1; P < .01.
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tional Surgical Quality Improvement Program database
also had surprisingly high rates of extended postoperative
LOS. Second, as a retrospective study, data that were not
collected for the prospective database or for clinical use
were unavailable for inclusion in the analysis. We expect
that this would lead to nondifferential missing data andbias our results toward the null. We have no data on preop-
erative patient functional status, availability of transporta-
tion, and adequacy of home care, all of which could
conceivably signiﬁcantly inﬂuence time to discharge. We
were also unable to capture discrete reasons for extended
LOS in most cases, since this information is only variably
captured in discharge summaries. Finally, we do not have
JOURNAL OF VASCULAR SURGERY
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how much cost savings we can expect from measures to
reduce LOS. However, our ﬁndings may inform future
cost-effectiveness studies.
CONCLUSIONS
In summary, this work adds to the evidence that post-
operative factors (particularly the number of complica-
tions) remain as important as preoperative patient
characteristics in determining risk for increased LOS.16
We anticipate that simple interventions on modiﬁable risk
factors will signiﬁcantly decrease the proportion of patients
requiring a single extra day of postoperative care. These
include early Foley catheter placement and removal on
the day of surgery to prevent urinary retention in at-risk
males and scheduling CEA cases to start in the morning
rather than after 12:00 pm. Intraoperative and postopera-
tive efforts to prevent and mitigate adverse events may
decrease the number of patients with increased LOS.
Finally, increased LOS following CEA may be a harbinger
for increased risk of long-term readmission and mortality.AUTHOR CONTRIBUTIONS
Conception and design: KH, AM, JM, MS, RB, LN, CO,
MB
Analysis and interpretation: KH, AM, MS, RB, LN, CO,
MB
Data collection: KH, AM, JM, RB
Writing the article: KM, AM, MS
Critical revision of the article: KH, AM, JM, MS, RB, LN,
CO, MB
Final approval of the article: KH, AM, JM, MS, RB, LN,
CO, MB
Statistical analysis: KH, AM, MS
Obtained funding: Not applicable
Overall responsibility: MBREFERENCES
1. Centers for Medicare & Medicaid Services Ofﬁces of the Actuary, Na-
tional Health Statistics Group; U.S. Department of Commerce, Bureau
of Economic Analysis; and U.S. Bureau of the Census. National health
expenditures; aggregate and per capita amounts, annual percent change
andpercent distribution: Selected calendar years, 1960-2011.Available at:
http://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-
Trends-and-Reports/NationalHealthExpendData/downloads/tables.
pdf. Accessed September 11, 2013.
2. Health Care Cost Institute, Inc. 2010 Health Care Cost and Utiliza-
tion Report. Available at: http://www.healthcostinstitute.org/2010
report. Accessed September 11, 2013.
3. Taheri PA, Butz DA, Greenﬁeld LJ. Length of stay has minimal impact
on the cost of hospital admission. J Am Coll Surg 2000;191:123-30.
4. Semel ME, Lipsitz SR, Funk LM, Bader AM, Weiser TG,
Gawande AA. Rates and patterns of death after surgery in the United
States, 1996 and 2006. Surgery 2012;151:171-82.
5. Birkmeyer JD, Stukel TA, Siewers AE, Goodney PP, Wennberg DE,
Lucas FL. Surgeon volume and operative mortality in the United
States. N Engl J Med 2003;349:2117-27.6. Reed AB, Gaccione P, Belkin M, Donaldson MC, Mannick JA,
Whittemore AD, et al. Preoperative risk factors for carotid endarter-
ectomy: deﬁning the patient at high risk. J Vasc Surg 2003;37:1191-9.
7. Bisdas T, Egorova N, Moskowitz AJ, Sosunov EA, Marin ML,
Faries PL, et al. The impact of gender on in-hospital outcomes after
carotid endarterectomy or stenting. Eur J Vasc Endovasc Surg
2012;44:244-50.
8. Lane JS, Shekherdimian S, Moore WS. Does female gender or hor-
mone replacement therapy affect early or late outcome after carotid
endarterectomy? J Vasc Surg 2003;37:568-74.
9. Roddy SP, Estes JM, Kwoun MO, O’Donnell TF Jr, Mackey WC.
Factors predicting prolonged length of stay after carotid endarterec-
tomy. J Vasc Surg 2000;32:550-4.
10. Sarac TP, Hertzer NR, Mascha EJ, O’Hara PJ, Krajewski LP,
Clair DG, et al. Gender as a primary predictor of outcome after carotid
endarterectomy. J Vasc Surg 2002;35:748-53.
11. Glaser J, Kuwuyama, D, Stone, D, Goodney, P, Schanzer, A, Scher-
merhorn, M, et al. Factors that determine length of stay after carotid
endarterectomy: opportunities to avoid hospital ﬁnancial losses. Pre-
sentation at the Society for Clinical Vascular Surgery 41st Annual
Symposium, Miami, FL, March 14, 2013.
12. Holloway RG Jr, Witter DM Jr, Mushlin AI, Lawton KB,
McDermott MP, Samsa GP. Carotid endarterectomy trends in the
patterns and outcomes of care at academic medical centers, 1990
through 1995. Arch Neurol 1998;55:25-32.
13. McPhee JT, Schanzer A, Messina LM, Eslami MH. Carotid artery
stenting has increased rates of postprocedure stroke, death, and
resource utilization than does carotid endarterectomy in the United
States, 2005. J Vasc Surg 2008;48:1442-50, 1450 e1441.
14. van de Pol MA, van Houdenhoven M, Hans EW, Boersma E, Bax JJ,
Feringa HH, et al. Inﬂuence of cardiac risk factors and medication on
length of hospitalization in patients undergoing major vascular surgery.
Am J Cardiol 2006;97:1423-6.
15. Cikrit DF, Larson DM, Sawchuk AP, Lalka SG, Shaﬁque S,
Dalsing MC. Short-stay carotid endarterectomy in a tertiary-care vet-
erans administration hospital. Am J Surg 2004;188:544-8.
16. Collins TC, Daley J, Henderson WH, Khuri SF. Risk factors for pro-
longed length of stay after major elective surgery. Ann Surg 1999;230:
251-9.
17. Girotti ME, Ko CY, Dimick JB. Hospital morbidity rankings and
complication severity in vascular surgery. J Vasc Surg 2013;57:158-64.
18. North American Symptomatic Carotid Endarterectomy Trial Collab-
orators. Beneﬁcial effect of carotid endarterectomy in symptomatic
patients with high-grade carotid stenosis. N Eng J Med 1991;325:
445-53.
19. Greenstein AJ, Chassin MR, Wang J, Rockman CB, Riles TS,
Tuhrim S, et al. Association between minor and major surgical com-
plications after carotid endarterectomy: results of the New York
Carotid Artery Surgery Study. J Vasc Surg 2007;46:1138-44; discus-
sion: 1145-6.
20. Youssef F, Jenkins MP, Dawson KJ, Berger L, Myint F, Hamilton G.
The value of suction wound drain after carotid and femoral artery
surgery: a randomised trial using duplex assessment of the volume of
post-operative haematoma. Eur J Vasc Endovasc Surg 2005;29:
162-6.
21. Morasch MD, Hirko MK, Hirasa T, Burke K, Greisler HP, Littooy FN,
et al. Intensive care after carotid endarterectomy: a prospective evalu-
ation. J Am Coll Surg 1996;183:387-92.
22. Doberstein CE, Goldman MA, Grossberg JA, Spader HS. The safety
and feasibility of outpatient carotid endarterectomy. Clin Neurol
Neurosurg 2012;114:108-11.
23. Angevine PD, Choudhri TF, Huang J, Quest DO, Solomon RA,
Mohr JP, et al. Signiﬁcant reductions in length of stay after carotid
endarterectomy can be safely accomplished without modifying either
anesthetic technique or postoperative ICU monitoring. Stroke
1999;30:2341-6.
24. Back MR, Harward TR, Huber TS, Carlton LM, Flynn TC, Seeger JM.
Improving the cost-effectiveness of carotid endarterectomy. J Vasc
Surg 1997;26:456-62; discussion: 463-4.
JOURNAL OF VASCULAR SURGERY
1290 Ho et al May 201425. Calligaro KD, Doerr KJ, McAfee-Bennett S, Mueller K,
Dougherty MJ. Critical pathways can improve results with carotid
endarterectomy. Sem Vasc Surg 2004;17:253-6.
26. Collier PE. Do clinical pathways for major vascular surgery improve
outcomes and reduce cost? J Vasc Surg 1997;26:179-85.
27. Hernandez N, Salles-Cunha SX, Daoud YA, Dosick SM, Whalen RC,
Pigott JP, et al. Factors related to short length of stay after carotid
endarterectomy. Vasc Endovasc Surg 2002;36:425-37.
28. Kaufman JL, Frank D, Rhee SW, Berman JA, Friedmann P. Feasibility
and safety of 1-day postoperative hospitalization for carotid endarter-
ectomy. Arch Surg 1996;131:751-5.29. LaMuraglia GM, Brewster DC, Moncure AC, Dorer DJ, Stoner MC,
Trehan SK, et al. Carotid endarterectomy at the millennium: what
interventional therapy must match. Ann Surg 2004;240:535-44; dis-
cussion: 544-6.
30. Su LT, Carpenter JP. Decreasing carotid endarterectomy length of stay
at a university hospital. Cardiovasc Surg 1999;7:292-7.
31. Syrek JR, Calligaro KD, Dougherty MJ, Doerr KJ, McAfee-Bennett S,
Raviola CA, et al. Five-step protocol for carotid endarterectomy in the
managed health care era. Surgery 1999;125:96-101.
Submitted Sep 17, 2013; accepted Nov 28, 2013.
